Taylor Brooks, MD
Treatment & Services
- Autologous Hematopoietic Stem Cell Transplant
- Bone Marrow Transplant (BMT)
- Cancer Center
- CAR T-Cell Therapy
- Cellular Therapy
- Chemotherapy
- Clinical Trials
- Experimental Therapeutics
- Hematology
- Hematopoietic Stem Cell Transplant
- Immunotherapy
- Stem Cell Transplant
Specialty in Diseases & Conditions
- Anaplastic Large Cell Lymphoma
- Brain Lymphoma
- Chronic Lymphocytic Leukemia
- HIV-related Lymphoma
- Lymphoma
- Lymphoplasmacytic Lymphoma
- Ocular Lymphomas
- Primary Central Nervous System (CNS) Lymphomas
- Sezary Syndrome
- Waldenstrom’s Macroglobulinemia
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Taylor Brooks, MD
Dr. Brooks is an oncologist specializing in the diagnosis and treatment of lymphoma who dedicated his career to helping patients navigate the complexities of lymphoma with personalized care and cutting-edge treatments.
Dr. Brooks completed specialized training in hematology and oncology at the Cleveland Clinic, where he developed a passion for caring for patients with lymphoma. He is actively involved in clinical research, staying up to date with the latest advancements in lymphoma therapies. Dr. Brooks believes in a patient-centered approach, where open communication, education, and emotional support are key aspects of the treatment journey. He works closely with each patient and their families to create individualized treatment plans that align with their unique needs and goals.
As a dedicated advocate for his patients, Dr. Brooks is committed to providing compassionate care every step of the way, from diagnosis through survivorship. He is an active member of professional organizations such as the American Society of Hematology and the American College of Physicians.
When not in the clinic, Dr. Brooks enjoys traveling, as well as spending time with his family, which helps him maintain a balanced and empathetic approach to patient care.
Education & Professional Highlights
Appointed
2024
Education & Fellowships
Fellowship - Cleveland Clinic
Hematology & Oncology
Cleveland,
OH
2024
Residency - Wake Forest Baptist Medical Center
Internal Medicine
Winston-Salem,
NC
2021
Medical Education - University of Cincinnati College of Medicine
Cincinnati,
OH United States
2018
Undergraduate - Ohio State University College of Medicine
Molecular Genetics
Columbus,
OH
2013
Certifications
- Internal Medicine
Specialty Interests
Lymphoma Diffuse large B-cell lymphoma Follicular lymphoma Marginal zone lymphoma Mantle cell lymphoma High-grade B-cell lymphoma Burkitt lymphoma HIV-related B-cell lymphoma Lymphoplasmacytic lymphoma (Waldenstrom macroglobulinemia) T-cell lymphoma
Research & Publications
See publications for Taylor Brooks, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 9/19/2024, Dr. Brooks has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
